uniQure Researchers Swap Out Lead Drug for a Better Prospect Post author:Sam Post published:October 18, 2017 Post category:BioPharma The company plans to expeditiously advance AMT-061 instead of AMT-060. Source: BioSpace You Might Also Like GTX Corp Provides Corporate Update And Reports Second Quarter 2017 Financial Results August 13, 2017 FDA Green Lights Gilead's Vosevi, With a Black Box Warning Attached July 18, 2017 AEterna Zentaris To Announce Second Quarter 2017 Financial And Operating Results On August 10, 2017 August 6, 2017
AEterna Zentaris To Announce Second Quarter 2017 Financial And Operating Results On August 10, 2017 August 6, 2017
